Evidence map›Paper›PMID 36146671›Full record

ArticleViruses2022

Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.

Ben Katowa, Annie Kalonda, Benjamin Mubemba, Japhet Matoba, Doreen Mainza Shempela, Jay Sikalima, Boniface Kabungo, Katendi Changula, Simbarashe Chitanga, Mpanga Kasonde and 16 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool.International journal of molecular sciences · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 6 countries.

Ben KatowaMacha Research Trust, Choma 20100, Zambia.ORCID 0000-0002-8935-9196
Annie KalondaDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-5540-469X
Benjamin MubembaDepartment of Wildlife Sciences, School of Natural Resources, Copperbelt University, Kitwe 50100, Zambia.ORCID 0000-0002-5266-3602
Japhet MatobaMacha Research Trust, Choma 20100, Zambia.
Doreen Mainza ShempelaChurches Health Association of Zambia, Lusaka 10101, Zambia.
Jay SikalimaChurches Health Association of Zambia, Lusaka 10101, Zambia.
Boniface KabungoSouthern Provincial Health Office, Ministry of Health, Choma 20100, Zambia.
Katendi ChangulaDepartment of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0003-2182-4319
Simbarashe ChitangaDepartment of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-5384-2493
Mpanga KasondeZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Otridah KaponaZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Nathan KapataZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Kunda MusondaZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Mwaka MonzeVirology Laboratory, University Teaching Hospital, Lusaka 10101, Zambia.
John TemboHerpeZ Infection Research and Training, University Teaching Hospital, Lusaka 10101, Zambia.
Matthew BatesHerpeZ Infection Research and Training, University Teaching Hospital, Lusaka 10101, Zambia.
Alimuddin ZumlaDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London NW3 2PF, UK.ORCID 0000-0002-5111-5735
Catherine G SutcliffeDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0001-8512-8326
Masahiro KajiharaDivision of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, N20 W10, Kita-ku, Sapporo 001-0020, Japan.ORCID 0000-0001-9478-0439
Junya YamagishiDivision of Collaboration and Education, International Institute for Zoonosis Control, Hokkaido University, N20 W10, Kita-ku, Sapporo 001-0020, Japan.
Ayato TakadaDepartment of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0003-2464-6642
Hirofumi SawaDepartment of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0003-2569-2755
Roma ChilengiZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Victor MukonkaZambia National Public Health Institute, Ministry of Health, Lusaka 10101, Zambia.
Walter MuleyaDepartment of Biomedical Sciences, School of Veterinary Medicine, University of Zambia, Lusaka 10101, Zambia.ORCID 0000-0001-8874-3965
Edgar SimulunduMacha Research Trust, Choma 20100, Zambia.ORCID 0000-0001-9423-0816
Ministry of Health · ZMUniversity of Zambia · ZMHokkaido University · JPUniversity Teaching Hospital · ZMChurches Health Assoication Of Zambia · ZMCopperbelt University · ZMGolden Valley Agricultural Research Trust · ZMJohns Hopkins University · USUCL Biomedical Research Centre · GBUniversity of Namibia · NA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) have significantly impacted the global epidemiology of the pandemic. From December 2020 to April 2022, we conducted genomic surveillance of SARS-CoV-2 in the Southern Province of Zambia, a region that shares international borders with Botswana, Namibia, and Zimbabwe and is a major tourist destination. Genetic analysis of 40 SARS-CoV-2 whole genomes revealed the circulation of Alpha (B.1.1.7), Beta (B.1.351), Delta (AY.116), and multiple Omicron subvariants with the BA.1 subvariant being predominant. Whereas Beta, Delta, and Omicron variants were associated with the second, third, and fourth pandemic waves, respectively, the Alpha variant was not associated with any wave in the country. Phylogenetic analysis showed evidence of local transmission and possible multiple introductions of SARS-CoV-2 VOCs in Zambia from different European and African countries. Across the 40 genomes analysed, a total of 292 mutations were observed, including 182 missense mutations, 66 synonymous mutations, 23 deletions, 9 insertions, 1 stop codon, and 11 mutations in the non-coding region. This study stresses the need for the continued monitoring of SARS-CoV-2 circulation in Zambia, particularly in strategically positioned regions such as the Southern Province which could be at increased risk of introduction of novel VOCs.

Indexed as

COVID-19SARS-CoV-2Codon, TerminatorGenomicsHumansMutationPhylogenyZambiaCodon, TerminatorCOVID-19SARS-CoV-2spike mutationsvariants of concernwhole-genome sequencingZambia

Identifiers

PMID36146671
PMCPMC9504048
OpenAlexW4293224826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.